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Abstract Neuroblastoma (NB), originating from neural
crest cells, is the most common extracranial tumor of child-
hood. Retinoic acid (RA) which is the biological active form
of vitamin A regulates differentiation of NB cells, and RA
derivatives have been used for NB treatment. PPARα (per-
oxisome proliferator-activated receptor) plays an important
role in the oxidation of fatty acids, carcinogenesis, and
differentiation. URG4/URGCP gene is a proto-oncogene
and that overexpression of URG4/URGCP is associated with
metastasis and tumor recurrence in osteosarcoma. It has been
known that URG4/URGCP gene is an overexpressed gene in
hepatocellular carcinoma and gastric cancers. This study
aims to detect gene expression patterns of PPARα and
URG4/URGCP genes in SH-SY5Y NB cell line after RA
treatment. Expressions levels of PPARα and URG4/URGCP
genes were analyzed after RA treatment for reducing differ-
entiation in SH-SY5Y NB cell line. To induce differentia-
tion, the cells were treated with 10 μMRA in the dark for 3–
10 days. Gene expression of URG4/URGCP and PPARα
genes were presented as the yield of polymerase chain reac-
tion (PCR) products from target genes compared with the
yield of PCR products from the glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) gene. SH-SY5Y cells possess
small processes in an undifferentiated state, and after treat-
ment with RA, the cells developed long neurites, resembling
a neuronal phenotype. PPARα gene expression increased in
RA-treated groups; URG4/URGCP gene expression de-
creased in SH-SY5Y cells after RA treatment compared with
that in the control cells. NB cell differentiation might asso-
ciate with PPARα and URG4/URGCP gene expression pro-
file after RA treatment.
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Introduction
Neuroblastoma (NB), originating from neural crest cells, is
the most common extracranial tumor of childhood. NB rep-
resents 8–10 % of all childhood tumors and is the most
common reason of cancer-related deaths in infancy [1]. Cy-
togenetic studies have shown that different chromosomal
rearrangements such as loss of 1p, loss of 11q, and gain of
17q are associated with NB prognosis and survival rates of
patients. MYCN gene amplification and chromosomal
rearrangements affect NB prognosis dependently with each
other or independently [2]. Retinoic acid (RA) which is the
biological active form of vitamin A has putative roles for
developing organs and systems, including nervous system,
in early embryonic period [3]. RA regulates the transition
from the proliferating precursor cell to the post-mitotic dif-
ferentiated cell and contributes to the morphological forma-
tion for distinct cell types [4–6]. RA derivatives have been
used for NB treatment and improves the increasing survival
rate of NB patients [7]. Peroxisome proliferator-activated
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receptors (PPARs) are associated with inflammatory re-
sponse, lipoprotein synthesis, and carcinogenesis [8–10].
Before transcriptional activation, PPARs heterodimerize
with retinoid X receptor and complex binds to peroxisome
response proliferator response element in the promoter re-
gion of target genes [11–13]. PPARα plays an important role
in the oxidation of fatty acid, and PPARα regulates the
expression of genes which are related to lipid and lipoprotein
metabolism [14, 15]. It has been known that PPARα induces
the development of cancer in the rodent liver and differenti-
ation in epidermal keratinocytes [16, 17]. Increasing concen-
trations of all-trans-retinoic (atRA) acid or 9-cis retinoic acid
(9cRA) induce brown adipocytes differentiation in culture
condition [18]. When brown adipocyte cells are exposed to
either atRA or 9cRA in a dose-dependent manner, PPARα
mRNA expression increases in differentiating brown adipo-
cytes [18]. Overexpression of URG4/URGCP gene which is
located in 7p13 is associated with metastasis and tumor
recurrence in osteosarcoma [19]. In metastasis, patients with
high expression of URG4/URGCP exhibit shorter survival
time [19]. It has been known that URG4/URGCP gene is an
overexpressed gene in hepatocellular carcinoma, gastric can-
cer, and osteosarcoma [19–21]. High expression level of
URG4 in HepG2 cells promotes hepatocellular cancer cell
growth and survival rate of cells in tissue culture and in nude
mice [21]. In this study, expression levels of PPARα and
URG4/URGCP genes were analyzed after RA treatment for
reducing differentiation in SH-SY5Y NB cell line. This
study aims to detect gene expression patterns of PPARα
and URG4/URGCP genes in SH-SY5Y NB cell line after
RA treatment.
Material and methods
SH-SY5Y cell culture and differentiation
Human SH-SY5Y neuroblastoma cell line was cultured in
DMEM-Ham’s F12 medium supplemented with 2 mM L-
glutamine, penicillin (20 units/ml), streptomycin (20 μg/ml),
and 10 % (v/v) heat-inactivated fetal calf serum at 37 °C in a
saturated humidity atmosphere containing 95 % air and 5 %
CO2. During culture, media were changed every 2 days, and
cells were replated before confluency. All experiments were
conducted with exponentially growing cells. To induce dif-
ferentiation, the cells were treated with 10 μMRA [22] in the
dark for 3–10 days. SH-SY5Y cells possess small processes
in an undifferentiated state, and after treatment with RA, the
cells developed long neurites, resembling a neuronal
phenotype.
RNA extraction and semi-quantitative reverse transcription-
polymerase chain reaction
Total RNA was isolated with Tri-reagent (Sigma, St. Louis,
MO, USA) according to the manufacturer instructions and
quantitated with a NanodropTM spectrophotometer (Thermo
Scientific). Reverse transcription (RT) reaction was
performed using the first strand cDNA synthesis kit (MBI
Fermentas, Vilnius, Lithuania) according to the manufac-
turer’s protocol. Appropriate cycles were chosen to ensure
the termination of PCR amplification before reaching a sta-
ble stage in each reaction. Gene expression was presented as
the yield of PCR products from target genes compared with
the yield of PCR products from the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) gene. PCR primers
and reaction parameters are listed in Table 1. Semi-
quantitative PCR products were analyzed by 2 % agarose
gel electrophoresis and were visualized by ethidium bromide
staining and photographed under UV light. In each instance,
the amount of RT-PCR product for the gene of interest was
normalized to the amount of GAPDH in the same sample.
The experiments were repeated two times using duplicates in
each group.
Results
The SH-SY5Y cells were initially treated with RA for 3–
10 days. SH-SY5Y cells possess small processes in an un-
differentiated state, and after treatment with RA, the cells
developed long neurites, resembling a neuronal phenotype.
Treatment of SH-SY5Y cells with 10 μM RA in the culture
medium resulted in neurite outgrowth that appeared on day 3
and extended on days 5, 7, and 10. This treatment yielded a
nearly pure population of differentiated cells characterized
Table 1 Primers used for RT-PCR
Primer name Sequence Amplicon size (bp) Annealing (°C)
URG4 F: 5′-CGGGAGATGGGACAGTTTTA-3′ 285 55
R: 5′-CATGGTGTTGAGGAGTGTGG-3′
PPARα F : 5′-CTTCATCCTGAGTCCCTACCG-3′ 472 55
R: 5′-GCCGTTCTGCTGCATTCG-3′
GAPDH F: 5′-CCCCACACACATGCACTTACC-3′ 98 55
R: 5′-CCTAGTCCCAGGGCTTTGATT-3′
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by abundant neurite outgrowth. The cells were harvested on
days 3, 5, 7, and 10, and total RNAwas extracted.
URG4/URGCP and PPARa gene mRNA expression
The quality of RNA samples was confirmed by electrophore-
sis of RNA through a 2 % agarose gel stained with ethidium
bromide. The A260/A280 ratio was between 1.9 and 2.0. The
effect of RA on URG4/URGCP and PPARa gene expressions
were shown in Figs. 1 and 2. Changes in mRNA levels,
detected using semi-quantitative RT-PCR, were calculated as
the proportion of the target gene amplification products to the
amplification products of the housekeeping gene GAPDH.
According to our results, PPARα gene expression increased
in RA-treated groups; URG4/URGCP gene expression de-
creased in SH-SY5Y cells after RA treatment compared with
that in the control cells (Figs. 1 and 2).
Discussion
Retinoids, like all-trans-retinoic acids, induces neuronal cell
differentiation, and because of this effect, they have been
used for NB therapy [7, 23]. Sung et al. designed three
different differentiation processes which are microcell-
mediated chromosome 1 transfer, MYCN gene knockdown,
and 9-cis-retinoic acid treatment for IMR-32 NB cells, and
expression levels of STMN4 and ROBO2 genes increased in
IMR-32 cells for all differentiation method [24]. Besides
upregulation of STMN4 and ROBO2 genes after differentia-
tion of NB cells, RA can induce neuronal differentiation in
neuroblastoma cells, which is associated with the induction
of HOX genes [25, 26]. It has been known that RA treatment
consistently induces cycle arrest of NB cells. RA increases
G1 phase cells and decreases G2 phase cells in SK-N-SH cell
line [27]. Qiao et al. demonstrated that expressions of CDK
inhibitors p21 and p27, which are important in regulating the
G1 phase checkpoint, are altered by RA in SK-N-SH cell line
[27]. In addition to increased expressions of CDK inhibitors
(p21 and p27), phosphorylated AKTand ERK1/2 expression
levels are increased in time-dependent treatment with RA in
SK-N-SH NB cells [27]. Qiao et. al also indicated that
suppression of PI3K and ERK1/2 affects transcriptional ac-
tivation of RA-RXR heterodimer in NB cells [27]. Although
signaling pathways and genes have been identified for NB
cell differentiation after RA treatment, RA-induced neuronal
differentiation has not been well understood. In this study, it
was investigated whether expression profiles of PPARα and
URG4/URGCP genes were associated with neuronal differ-
entiation for SH-SY5Y NB cells after RA treatment in time-
dependent manner. It has been known that PPARα induces
the development of cancer in the rodent liver [28, 29] and
PPARα activation, by its agonist WY14643, induces cell
proliferation in MCF-7 and MDA-MB-231 breast cancer cell
lines [30]. Although PPARα has oncogene role in hepatocel-
lular carcinoma and breast cancer, PPARα activation induces
cell cycle arrest and apoptosis in Ishikawa endometrial can-
cer cells [31]. Interestingly, PPARα-mediated differentiation
process is activated by farnesol in epidermal keratinocytes
[17]. In this study, SH-SY5Y neuroblastoma cell line was
treated with 10 μM RA to induce neuronal differentiation
[22]. Neurite outgrowth was observed after a 3-day period;
afterwards, RA treatment and cell culture time were extend-
ed on days 5, 7, and 10 after the first RA treatment. We
detected that SH-SY5Y neuroblastoma cell line expressed
PPARα gene without RA treatment [32, 33], and PPARα
expression was also detected in each time period for RA-
mediated neural differentiation. PPARα expression after RA
treatment was more than that of the control, not treated with
RA, and PPARα expression increased after RA treatment in
time-dependent manner, and there was a correlation between
time-dependent doses of RA and PPARα expression. We
showed that PPARα gene expression increases in RA-
mediated neuronal differentiation. Contrary to PPARα ex-
pression, URG4/URGCP gene expression decreased in time-
dependent manner after RA treatment when URG4/URGCP
gene expression is compared to that of the control cells
which were not treated with RA. Overexpression of
URG4/URGCP gene have been detected in hepatocellular
carcinoma, gastric cancer, and osteosarcoma [19–21].
siRNA-mediated suppression of URG4/URGCP gene in
HEpG2 cell line and non-suppressed HEpG2 cell line exhibit
different miRNA profiles. HEpG2 cell line which express
URG4/URGCP gene shows alteration in miRNA patterns
which are related with carcinogenesis [34]. Overexpression
of URG4/URGCP gene reduces p21Cip1 and p27Kip1 cell-
cycle inhibitors and upregulates cyclin D1 in hepatocellular
carcinoma cells [35]. High expression of URG4/URGCP
1 2 3 4 5
Fig. 1 Expression of peroxisome proliferator activation receptor
(PPARα). RT-PCR analysis of PPAR showed increase of expression
compared to that of the control, 3.25 % in 3 days (lane 2), 8.94 % in
5 days (lane 3), 7.72 % in 7 days (lane 4), and 2.84 % in 10 days (lane 5)
1                    2                    3                 4                     5
Fig. 2 Expression of upregulated gene 4 (URG4). RT-PCR analysis of
URG4 showed decrease expression compared to that of the control
7.63 % in 3 days (lane 2), 12 % in 5 days (lane 3), 13.45 % in 7 days
(lane 4), and 28.72 % in 10 days (lane 5)
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gene in acute lymphoblastic leukemia patients is correlated
with high expression of cell cycle related genes such as
CCNG1, CCNC, and CDC16 [36]. We detected that
URG4/URGCP gene expression was decreased in SH-SY5Y
cells after RA-treated cells compared to that in the control
cells. In order that URG4/URGCP gene exhibits proto-
oncogene function and induces cell cycle process, decreasing
of URG4/URGCP gene might be important for differentiation
of NB cells. NB cell differentiation might be associated with
PPARα andURG4/URGCP genes expression profile after RA
treatment.
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